Insider Transactions in Q3 2022 at Chemo Centryx, Inc. (CCXI)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2022
|
Susan M Kanaya Director |
SELL
Open market or private sale
|
Direct |
19,898
-17.89%
|
$994,900
$50.95 P/Share
|
|
Aug 16
2022
|
Susan M Kanaya Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,898
+15.18%
|
$198,980
$10.86 P/Share
|
|
Aug 04
2022
|
Thomas J. Schall President and CEO |
SELL
Open market or private sale
|
Direct |
130,000
-5.15%
|
$6,500,000
$50.24 P/Share
|
|
Aug 04
2022
|
Thomas J. Schall President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
130,000
+4.9%
|
$1,820,000
$14.28 P/Share
|
|
Aug 04
2022
|
Susan M Kanaya Director |
SELL
Open market or private sale
|
Direct |
46,298
-33.64%
|
$2,314,900
$50.17 P/Share
|
|
Aug 04
2022
|
Susan M Kanaya Director |
BUY
Exercise of conversion of derivative security
|
Direct |
46,298
+15.42%
|
$277,788
$6.43 P/Share
|
|
Aug 04
2022
|
James L Tyree Director |
SELL
Open market or private sale
|
Direct |
10,000
-52.25%
|
$500,000
$50.22 P/Share
|
|
Aug 04
2022
|
Markus J. Cappel Chief Bus. Officer & Treasurer |
SELL
Open market or private sale
|
Direct |
7,564
-7.94%
|
$378,200
$50.22 P/Share
|